維生素A Vitamin A × 維他命 A 缺乏症（含夜盲症、乾眼症、兒童高死亡率風險）
結論：證據支持
這是 intervention 與 condition 為同義因果配對的旗艦案例：維生素 A 缺乏症的定義即由維生素 A 不足造成，補充即為直接病因治療。
A 🔵 A 中度證據 已發布 ⚠️ medium — moderate promotional content
這是 intervention 與 condition 為同義因果配對的旗艦案例：維生素 A 缺乏症的定義即由維生素 A 不足造成，補充即為直接病因治療。
Cochrane Imdad 2017 高品質證據（47 trials, n>1.2M, RR 0.88 全死因死亡）、Mayo-Wilson 2011（RR 0.76）、WHO 2011 強推薦（GRADE strong）、EML 收載、NIH ODS 明列血清視黃醇診斷閾值與既定療法、Cleveland Clinic 載明高劑量起始續以低劑量治療方案，多源證據一致且方向相同。
DEVTA 2013 RR 0.96 為唯一鈍化訊號，但已被 Cochrane 納入仍維持 pooled benefit，且情境（基線 VAD 較輕、麻疹疫苗覆蓋上升）已被解釋。
屬罕見能達 S 級的營養素—疾病配對。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.78
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
A · 已發布
信心度
89%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧／統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.783
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
結論：Vitamin A supplementation reduced all-cause mortality by 12% (RR 0.88, 95% CI 0.83 to 0.93; 19 trials, n=1,202,382; high-certainty evidence). VAS also reduced diarrhoea-specific mortality (RR 0.88, 95% CI 0.79 to 0.98), measles incidence (RR 0.50, 95% CI 0.37 to 0.67), diarrhoea incidence (RR 0.85, 95% CI 0.82 to 0.87), night blindness (RR 0.32) and xerophthalmia (RR 0.31). Authors conclude VAS is associated with a clinically meaningful reduction in mortality, morbidity and vision-related outcomes in children at risk of deficiency.
前往 PubMed
Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
結論：Pooled analysis of 17 trials (n≈194,000) showed VAS reduced all-cause mortality by 24% (RR 0.76, 95% CI 0.69 to 0.83). Diarrhoea-specific mortality fell 28% (RR 0.72, 95% CI 0.57 to 0.91); measles-specific mortality fell 20% (non-significant). Incidence of diarrhoea (RR 0.85) and measles (RR 0.50) was reduced. Authors estimate that universal VAS in deficient settings could prevent ~600,000 child deaths/year and recommend continued public-health implementation pending DEVTA results.
前往 PubMed
Effect of six-monthly vitamin A supplementation on all-cause mortality of pre-school children in north India (DEVTA): cluster-randomised trial
結論：Mortality rate ratio in VAS vs control clusters was 0.96 (95% CI 0.89 to 1.03), corresponding to a non-significant 4% mortality reduction — substantially smaller than the ~23% reduction expected from earlier meta-analyses. Authors conclude that in this north-Indian population where baseline vitamin A deficiency was moderate and measles vaccination coverage rising, 6-monthly VAS conferred no statistically significant mortality benefit. Results re-ignited debate but did not overturn Cochrane meta-analytic conclusion that VAS reduces mortality in deficient settings.
前往 PubMed
Vitamin A supplementation during pregnancy for maternal and newborn outcomes
結論：Prenatal vitamin A supplementation reduced maternal night blindness substantially (RR 0.79, 95% CI 0.64 to 0.98) and reduced maternal anaemia (RR 0.81). No significant effect on maternal mortality overall, though one large Nepali trial (Christian/West) had suggested benefit. Supports vitamin A supplementation in pregnant women with deficiency, particularly for night blindness and anaemia.
前往 PubMed
Guideline: Vitamin A Supplementation in Infants and Children 6–59 Months of Age
結論：Strong recommendation (high-quality evidence) for periodic high-dose VAS in children 6-59 months in vitamin A-deficient settings, based on consistent mortality reduction (~24%) from RCT meta-analyses. Guideline reaffirms VAS as a flagship global public-health intervention; subsequent 2017 Cochrane update (PMID 28282701) maintained the recommendation despite DEVTA's smaller effect.
前往 PubMed
L4a US FDA
支持
Vitamin A — GRAS — 21 CFR 184.1245, 184.1930 — Technical Effect: NUTRIENT SUPPLEMENT — SCOGS no. 118 來源↗
L4b EU EFSA
中性
Vitamin A contributes to the normal function of the immune system; Vitamin A contributes to the maintenance of normal vision; Vitamin A contributes to the maintenance of normal skin; Vitamin A contributes to the maintenance of normal mucous membranes; Vitamin A has a role in the process of cell specialisation; Vitamin A contributes to normal iron metabolism. 來源↗
L4c UK NHS
謹慎
Do not take cod liver oil or any supplements containing vitamin A (retinol) when you're pregnant. Too much vitamin A could harm your baby. 來源↗
L4d TW TFDA / 衛福部
中性
維生素A 指示藥每日用量上限 10,000 IU（3,000 微克 RE）；換算：1 微克 RE = 1 微克 Retinol = 6 微克 β-Carotene；3 微克 RE = 10 IU。 來源↗
L4e WHO
支持
In settings where vitamin A deficiency is a public health problem, vitamin A supplementation is recommended in infants and children 6-59 months of age as a public health intervention to reduce child morbidity and mortality (strong recommendation). 來源↗
L5a NIH Office of Dietary Supplements
支持
The most common clinical sign of vitamin A deficiency is xerophthalmia, which develops after plasma retinol has been low. The first sign is night blindness, or the inability to see in low light or darkness as a result of low rhodopsin levels in the retina. 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
支持
Your healthcare provider will treat your vitamin A deficiency with high doses of a vitamin A supplement for several days. After several days, they'll have you take lower doses of vitamin A until your vision and skin issues start to resolve. 來源↗
L5d Harvard Health
支持
Vitamin A deficiency is rare in Western countries but may occur. ... Also at risk are adults and children who eat a very limited diet due to poverty or self-restriction. 來源↗
L5e Specialty Society (condition-mapped)
支持
In settings where vitamin A deficiency is a public health problem (prevalence of night blindness is 1% or higher in children 24–59 months of age or where the prevalence of vitamin A deficiency (serum retinol 0.70 µmol/l or lower) is 20% or higher in infants and children 6–59 months of age), high-dose vitamin A supplementation is recommended in infants and children 6–59 months of age (strong rec… 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
台灣 PTT/Dcard/Mobile01 對『維他命A 缺乏症（夜盲症、乾眼症、兒童高死亡率）』本身幾乎沒有在地實測心得——維生素A缺乏屬開發中國家問題，台灣現代飲食罕見，鄉民根本不以『缺乏症』為主題討論。維生素A零星出現的脈絡有二：一是眼睛保健（有藥師指口服維生素A或維生素A眼藥水對乾眼症有幫助），但整體護眼話題被葉黃素、魚油、蝦紅素、花青素壓倒性蓋過，維他命A只是配角；二是 BeautySalon 把維他命A當作皮膚角質代謝/抗痘成分討論（與本 condition 無關）。社群幾乎不會單獨購買維生素A補充劑，多透過綜合維他命或魚肝油攝取。針對夜盲症與兒童高死亡率，台灣社群基本無討論，故 anecdotal_efficacy 標為無共識、confidence 壓低。
💬社群實感
無共識（針對『維他命A 缺乏症/夜盲症/乾眼症』的在地維生素A實測心得幾乎闕如；護眼話題的正面回饋集中在葉黃素、魚油、蝦紅素，維他命A僅零星被藥師提及對乾眼症有幫助，且夜盲症與兒童死亡率風險在台灣社群完全無討論）
破解迷思 社群最常見的 5 個誤解
✓
事實誤以為乾眼症、眼睛乾澀就要補維生素A，其實台灣現代飲食極少真正缺乏A，乾眼症多為淚液分泌/蒸發問題，須就醫分型而非自行補A
✓
事實把維生素A與『護眼=葉黃素/魚油/蝦紅素』混為一談，誤以為都是同一類護眼補充品（機轉與適應症不同）
✓
事實誤以為維生素A是水溶性、可隨意多補（實為脂溶性，過量會在體內囤積中毒，孕婦過量還有致畸風險）
✓
事實誤以為靠保健品就能取代就醫，忽略真正夜盲/乾眼須由眼科診斷病因
✓
事實把『維他命A抗痘/角質代謝（A酸、A醇護膚）』與『治療維生素A缺乏症』混淆
🩹 社群通報的副作用
- 脂溶性維生素A過量囤積中毒：噁心、嘔吐、腹痛、掉髮（社群零星轉述衛教，非個人實測）
- 孕婦攝取過量維生素A有胎兒致畸風險（偶被提醒）
- 社群針對『維生素A單方治療缺乏症』本身幾乎無第一手副作用回報，因鮮少有人這樣使用
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 魚肝油（社群最常被當作維生素A天然來源，非特定品牌）
- 綜合維他命（如萊翠美、開架大廠綜合錠，多人透過綜合配方攝取微量A，而非單方）
- iHerb 海外網購單方/綜合維生素A（純素或想精準補充者偶提）
- （針對乾眼症，社群實際推薦的多為葉黃素、魚油、蝦紅素而非維生素A單方）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 醫療高劑量維生素 A 補充治療
- 食物強化計畫
- 飲食多樣化
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-vitamin-a-deficiency-INT-vitamin-a-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "維生素A能改善維他命 A 缺乏症（含夜盲症、乾眼症、兒童高死亡率風險）",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 4,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🔵 A 中度證據"
}
}